MedTrace Logo

Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus

NCT05922722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-03-05

No results posted yet for this study

Summary

The purpose of this research study is to collect information from lupus patients about their experience with a tool that informs patients about the benefits vs. harms of a medication such as hydroxychloroquine. The main question it aims to answer is whether the decision-making tool will increase medication adherence.

Participants will be asked to complete questionnaires that assess their understanding of the decision-making tool.

Conditions

Interventions

OTHER

Decision-making tool

The shared decision-making tool is a paper tool or an electronic version which will be available in the clinics for clinic team's use.

OTHER

Questionnaire

Questionnaire to assess participant's understanding of the decision-making tool

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Shivani Garg, MD, MS · University of Wisconsin, Madison

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-15
Primary Completion
2025-02-20
Completion
2025-02-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05922722 on ClinicalTrials.gov